Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,396 | 478 | 90.8% |
| Travel and Lodging | $694.13 | 4 | 6.1% |
| Education | $357.68 | 5 | 3.1% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,859 | 101 | $0 (2024) |
| NeoTract Inc. | $933.13 | 7 | $0 (2019) |
| Janssen Biotech, Inc. | $705.19 | 33 | $0 (2024) |
| ABBVIE INC. | $649.64 | 35 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $560.32 | 23 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $504.99 | 27 | $0 (2023) |
| PFIZER INC. | $467.08 | 22 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $443.51 | 21 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $429.27 | 16 | $0 (2024) |
| Boston Scientific Corporation | $423.99 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,796 | 72 | Teleflex LLC ($184.26) |
| 2023 | $2,227 | 88 | Astellas Pharma US Inc ($401.80) |
| 2022 | $1,344 | 64 | Astellas Pharma US Inc ($191.89) |
| 2021 | $1,253 | 62 | Astellas Pharma US Inc ($231.66) |
| 2020 | $349.67 | 21 | Astellas Pharma US Inc ($183.68) |
| 2019 | $2,136 | 67 | NeoTract Inc. ($822.35) |
| 2018 | $1,226 | 64 | Astellas Pharma US Inc ($294.01) |
| 2017 | $1,117 | 58 | Amgen Inc. ($158.47) |
All Payment Transactions
496 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $150.87 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/04/2024 | Endo USA, Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $28.39 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 11/19/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Urology Gynecology | ||||||
| 11/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.80 | General |
| 10/31/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $57.65 | General |
| Category: rezum_URO | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Oncology | ||||||
| 10/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/01/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/30/2024 | Endo USA, Inc. | AVEED (Biological), EDEX, XIAFLEX | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: UROLOGY | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,857 | 3,352 | $1.2M | $200,952 |
| 2022 | 22 | 2,990 | 3,492 | $798,394 | $186,690 |
| 2021 | 25 | 2,760 | 3,398 | $1.1M | $183,400 |
| 2020 | 26 | 2,418 | 3,090 | $1.2M | $167,760 |
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 381 | 459 | $138,159 | $47,662 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 541 | 626 | $166,516 | $44,445 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 174 | 174 | $69,600 | $24,033 | 34.5% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 27 | 27 | $70,443 | $16,753 | 23.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 187 | 220 | $95,700 | $14,889 | 15.6% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 167 | 185 | $49,025 | $9,382 | 19.1% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 15 | $82,240 | $5,853 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 60 | 60 | $18,060 | $4,928 | 27.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 401 | 504 | $30,744 | $4,854 | 15.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 43 | 43 | $24,725 | $4,614 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $12,123 | $4,381 | 36.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 313 | 368 | $7,286 | $3,064 | 42.1% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 15 | 15 | $88,575 | $2,776 | 3.1% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 15 | 56 | $248,920 | $2,496 | 1.0% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 22 | 22 | $9,042 | $2,245 | 24.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 15 | 16 | $9,920 | $2,149 | 21.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 31 | $4,495 | $1,758 | 39.1% |
| 55899 | Other procedure on male genital system | Office | 2023 | 13 | 13 | $10,920 | $1,405 | 12.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 43 | 43 | $13,975 | $1,164 | 8.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 18 | $4,788 | $1,059 | 22.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 334 | 397 | $1,985 | $870.38 | 43.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 14 | 14 | $2,730 | $170.95 | 6.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 506 | 607 | $161,462 | $43,629 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 353 | 416 | $125,216 | $41,840 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 141 | 141 | $56,560 | $19,563 | 34.6% |
About Dr. Vikrant Uberoi, M.D
Dr. Vikrant Uberoi, M.D is a Urology healthcare provider based in Towson, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1063672871.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikrant Uberoi, M.D has received a total of $11,448 in payments from pharmaceutical and medical device companies, with $1,796 received in 2024. These payments were reported across 496 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($10,396).
As a Medicare-enrolled provider, Uberoi has provided services to 11,025 Medicare beneficiaries, totaling 13,332 services with total Medicare billing of $738,803. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Towson, MD
- Active Since 06/15/2008
- Last Updated 03/12/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1063672871
Products in Payments
- UroLift (Device) $933.13
- XTANDI (Drug) $869.32
- MYRBETRIQ (Drug) $602.00
- GEMTESA (Drug) $434.98
- XIAFLEX (Biological) $428.81
- BOTOX (Biological) $416.73
- ERLEADA (Drug) $393.27
- Nubeqa (Drug) $391.51
- PROVENGE (Drug) $388.50
- Myrbetriq (Drug) $353.78
- ORGOVYX (Drug) $349.52
- PROLARIS (Device) $291.36
- PYLARIFY (Drug) $248.12
- iTIND System (Device) $247.57
- Xtandi (Drug) $245.12
- UROLIFT (Device) $243.34
- ELIGARD (Drug) $208.27
- LUPRON DEPOT (Drug) $203.29
- Erleada (Drug) $199.61
- KEYTRUDA (Biological) $195.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Towson
Jonathan Rubenstein, M.d, M.D
Urology — Payments: $24,567
Karen Boyle, M.d, M.D
Urology — Payments: $23,010
Benjamin Cohen, M.d, M.D
Urology — Payments: $12,984
Marc Siegelbaum, Md, MD
Urology — Payments: $12,980
Dr. David Stampfer, Md, MD
Urology — Payments: $9,589
Daniel Dietrick, M.d, M.D
Urology — Payments: $7,872